Replies to post #23043 on Revive Therapeutics Ltd (RVVTF)

[hotmeat]

So according to your analysis, MindMed in 2020, and the "rookie" MF at Revive, along with the "rookie" management teams at Mydecine, MindCure Psyched, Cybin, Numinus and Field Trip all made the same ""terrible"" decision simultaneously???

Have you actually looked at the other deals? They're all basically the same, the only difference is how much the shares were discounted.

This seems to be accounted for in part by how large the initial share purchase was, ie, the larger the buy, the "bigger" the discount.

The Warrants are all approximately 140%-150% of the share buy price.

Glad to know we have such talented posters here to warn us about the managerial malpractice at Revive.

WOW!!!

[medicinecat]

Yes I agree, the timing of this offering makes no sense. If they're expecting positive phase 3 results and a positive ETF catalyst then why put up the offering beforehand? It smells like an act of desperation. And yes I agree the longs are getting hurt here. It doesn't matter if the pending news is good or bad, the the longs are taking it in the shorts.